Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Adlai Nortye (ANL)

Adlai Nortye Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANL
DateTimeSourceHeadlineSymbolCompany
24/05/202402:03GlobeNewswire Inc.Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024NASDAQ:ANLAdlai Nortye Ltd
22/05/202413:00GlobeNewswire Inc.Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation TherapyNASDAQ:ANLAdlai Nortye Ltd
13/05/202421:29Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANLAdlai Nortye Ltd
29/03/202410:00GlobeNewswire Inc.Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & DevelopmentNASDAQ:ANLAdlai Nortye Ltd
17/11/202312:30GlobeNewswire Inc.Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCCNASDAQ:ANLAdlai Nortye Ltd
23/10/202313:12GlobeNewswire Inc.Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster AwardNASDAQ:ANLAdlai Nortye Ltd
03/10/202317:05GlobeNewswire Inc.Adlai Nortye Ltd. Announces Closing of Initial Public OfferingNASDAQ:ANLAdlai Nortye Ltd
29/09/202307:46GlobeNewswire Inc.Adlai Nortye Ltd. Announces Pricing of Initial Public OfferingNASDAQ:ANLAdlai Nortye Ltd
 Showing the most relevant articles for your search:NASDAQ:ANL